VOLUME 14, ISSUE 18 / SEPTEMBER 2022
Commentary
NOVEMBER 2022
An insight into the presence of impurities in reference standards and their impact on mass spectrometry-based bioanalysis
- Ashok M Ghoghari
, - Harilal V Patel &
- Mukul R Jain
- Pages:1191–1195
- Published Online:15 November 2022
Methodology
NOVEMBER 2022
Development and validation of methods that enable high-quality droplet digital PCR and hematological profiling data from microvolume blood samples
- Bin Xu &
- Ryan Haley
- Pages:1197–1211
- Published Online:4 November 2022
Preliminary Communication
NOVEMBER 2022
Development and multicenter validation of an LC–MS-based bioanalytical method for antisense therapeutics
- Yuchen Sun ,
- Shin-ichiro Nitta,
- Kosuke Saito ,
- Ryuta Hosogai,
- Keiko Nakai,
- Ryoya Goda,
- Hisao Shimizu ,
- Hisashi Fujita,
- Masaaki Kakehi,
- Kazuyuki Murata,
- Takeru Yamaguchi,
- Takeshi Okuzono,
- Shinichi Yamane,
- Mitsuhiko Kawabata,
- Takayuki Matsunuma,
- Kentaro Takahara,
- Noriko Kato,
- Masaki Yamada,
- … See all authors
- Pages:1213–1227
- Published Online:21 November 2022
Research Article
NOVEMBER 2022
Development of a selective, sensitive and robust oxyntomodulin dual monoclonal antibody immunoassay
- Tara S Umberger ,
- Wenyu Ming,
- Jennifer M Cox,
- Robert J Konrad &
- Robert W Siegel
- Pages:1229–1239
- Published Online:15 November 2022
Research Article
NOVEMBER 2022
Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum
- Oladipo S Idowu ,
- Jenny L Craigen,
- Gareth J Veal &
- David Jamieson
- Pages:1241–1249
- Published Online:15 November 2022